Cleared Traditional

K182987 - Genesys Spine 3DP Lumbar Interbody System

K182987 is the FDA 510(k) clearance for Genesys Spine 3DP Lumbar Interbody System by Genesys Spine. It is a Class 2 Orthopedic device (product code MAX) cleared through the Traditional 510(k) pathway after a 409-day FDA review.

K182987 · Genesys Spine · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2019
Decision
409d
Days
Class 2
Risk

K182987 is an FDA 510(k) clearance for the Genesys Spine 3DP Lumbar Interbody System. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Genesys Spine (Austin, US). The FDA issued a Cleared decision on December 12, 2019 after a review of 409 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Genesys Spine devices

Submission Details

510(k) Number K182987 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 2018
Decision Date December 12, 2019
Days to Decision 409 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
287d slower than avg
Panel avg: 122d · This submission: 409d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 603
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K182987.
Pantheon Spinal Pontus Interbody Fusion Device
K181548 · Pantheon Spinal · Dec 2019
Keos Lumbar IBFD
K193174 · Keos · Dec 2019
Neo Cage System
K191796 · Neo Medical SA · Dec 2019
SeaSpine Beachside System
K192132 · SeaSpine Orthopedics Corporation · Dec 2019
Peridot Intervertebral body fusion System
K192026 · Gbs Commonwealth Co., Ltd. · Nov 2019
Cortina™ [MAX] Lumbar Cage System
K192248 · Neurostructures, Inc. · Nov 2019